Stroke is a significant complication of sickle cell anemia in the pediatric population. The pathophysiology of stroke in sickle cell anemia remains unclear. Protein C and protein S activities were measured in children with sickle cell anemia and stroke, and compared to those with sickle cell anemia who were neurologically normal. Results showed significantly decreased levels of both protein C and protein S activities in children with sickle cell anemia who have had a stroke. This pilot study suggests that a possible coagulopathic state in children with sickle cell anemia may be associated with an increased risk for cerebrovascular disease. Further research in this area is indicated. (J Child Neurol 1997;12:19-21).
Get full access to this article
View all access options for this article.
References
1.
Powars D., Chan LS, Schroeder WA: The variable expression of sickle cell disease is genetically determined . Semin Hematol1990;27:360-376.
2.
Ohene-Frempong K.: Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations. Semin Hematol1991;28:213-219.
3.
Portnoy BA, Herion JC: Neurological manifestations in sickle cell disease. Ann Intern Med1972;76:643-652.
4.
Baird RL: Studies in sickle cell anemia: Clinicopathological aspects of neurological manifestations. Pediatrics1964;34:92-100.
5.
Stockman JA, Nigro MA, Mishkin MM, Oski FA: Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med1972;287:846-849.
6.
Adams RJ, Nichols FT, McKie K.: Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI. Neurology1988;38:1012-1017.
7.
Francis RB: Large-vessel occlusion in sickle cell disease: Pathogenesis, clinical consequences, and therapeutic implications. Medical Hypotheses1991;35:85-95.
8.
Merkel KHH , Ginsberg PL, Parker JC, Donovan-Post MJ: Cerebrovascular disease in sickle cell anemia: A clinical, pathological, and radiological correlation. Stroke1978;9:45-52.
9.
Wilimas J., Goff JR, Anderson HR, et al: Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr1980;96:205-208.
10.
Russell MO, Goldberg HI, Hodson A., et al: Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood1984;63:162-169.
11.
Wang W., Kovnar EH, Tonkin IL, et al: High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. JPediatr1991;118:377-382.
12.
Cohen AR, Martin MB, Silber JH, et al: A modified transfusion program for prevention of stroke in sickle cell disease. Blood1992;79:1657-1661.
13.
Pavlakis SG , Prohovnik I., Piomelli S., DeVivo DC: Neurologic complications of sickle cell disease . Adv Pediatr1989;36:247-276.
14.
Seligsohn V. , Berger A., Abend M.: Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med1984;310:559-562.
15.
van Kuijck MAP , Rotteveel J., van Oostrom CG, Novakova I.: Neurological complications in children with protein c deficiencyNeuropediatrics1994;25:16-19.
16.
Israels SJ, Sechia SS: Childhood stroke associated with protein c or s deficiency. J Pediatr1987;111:562-564.
17.
Brown DC, Livingston JH, Minns RA, Eden OB: Protein c and s deficiency causing childhood stroke. Scott Med J1993;38:114-115.
18.
Esmon CT: Protein C: Biochemistry, physiology and clinical implications. Blood1983;62:1155-1158.
19.
Rick ME: Protein C and protein S. JAMA1990 ;263:701-703.
20.
Karayalcin G., Lanzkowsky P.: Plasma protein C levels in children with sickle cell disease. Am J Pediatr Hematol Oncol1989;11:320-323.
21.
Marfaing-Koka A., Boyer-Neumann C., Wolf M., et al: Decreased protein S activity in sickle cell disease. Nouv Rev Fr Hematol1993;35:425-430.
22.
Francis RB: Protein S deficiency in sickle cell anemia. JLabClin Med1988;111:571-576.
23.
Leikin SL, Gallagher D., Kinney TR, et al: Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics1989;84:500-508.
24.
Lane PA, O'Connell JL, Marler RA: Irreversibly sickled cells bind protein s: An indication of altered membrane phospholipid asymmetry. Am J Hematol1994;47:295-300.
25.
Leslie J., Langler D., Serjeant GR, et al: Coagulation changes during the steady state in homozygous sickle cell disease in Jamaica. Br J Haematol1992 ;30:159-166.
